Question

As a financial analyst, you have just been handed the 2012 financial report of Firm A, a large, global pharmaceutical company. Firm A competes in both traditional pharmaceutical products and in evolving biotechnology products. The following data (in billions) on Firm A and the pharmaceutical industry are available:


Given these data, evaluate the cost management performance of FirmA.


$1.99
Sales9
Views293
Comments0
  • CreatedJune 03, 2014
  • Files Included
Post your question
5000